Rekrutierung

Eingeschlossene Patienten: 23.559 (Stand 02. Juni 2025)
Amgevita® (Adalimumab)	252
Benepali® (Etanercept)	1277
Cimzia® (Certolizumab)	1051
Enbrel® (Etanercept)	2878
Erelzi® (Etanercept)	606
Flixabi® (Infliximab)	10
Hukyndra® (Adalimumab)	16
Hulio® (Adalimumab)	295
Humira® (Adalimumab)	2912
Hyrimoz® (Adalimumab)	273
Idacio® (Adalimumab)	71
Imraldi® (Adalimumab)	246
Inflectra™ (Infliximab)	16
Jyseleca® (Filgotinib)	175
Kevzara® (Sarilumab)	234
Kineret® (Anakinra)	89
MabThera® (Rituximab)	1459
Nepexto® (Etanercept)	101
Olumiant® (Baricitinib)	560
Orencia® (Abatacept)	998
Remicade® (Infliximab)	762
Remsima® (Infliximab)	27
Rinvoq® (Upadacitinib)	336
Rixathon® (Rituximab)	20
RoActemra® (Tocilizumab)	1381
Ruxience® (Rituximab)	1
Simponi® (Golimumab)	479
Truxima® (Rituximab)	7
Tyenne® (Tocilizumab)	64
Xeljanz® (Tofacitinib)	403
Yuflyma® (Adalimumab)	60
Zessly® (Infliximab)	2
Kontrollen	6498